Form 8-K - Current report:
SEC Accession No. 0001193125-20-239042
Filing Date
2020-09-03
Accepted
2020-09-03 16:06:29
Documents
4
Period of Report
2020-08-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d18915d8k.htm 8-K 25612
2 EX-99.1 d18915dex991.htm EX-99.1 13556
3 EX-99.2 d18915dex992.htm EX-99.2 91191
4 GRAPHIC g18915g0903064426349.jpg GRAPHIC 2912
  Complete submission text file 0001193125-20-239042.txt   135890
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Unum Therapeutics Inc. (Filer) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38443 | Film No.: 201159344
SIC: 2834 Pharmaceutical Preparations